Denis O Okumu

6PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2026
Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer.

|Jul 28, 2026
Kinase Plasticity with Vandetanib Treatment Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast Cancer.

|Mar 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers.

Matthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson

|Feb 20, 2025
Kinase Plasticity in Response to Vandetanib Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast Cancer.

Rasha T Kakati, Austin A Whitman, Santiago Haase

|Feb 05, 2025
Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.

Smita Matkar, Michael P East, Timothy J Stuhlmiller

|May 19, 2017
BIRC6 mediates imatinib resistance independently of Mcl-1.

Denis O Okumu, Michael P East, Merlin Levine

Pageof 1

Frequent Collaborators

4 joint publications

Michael P East

4 joint publications

Charles M Perou

3 joint publications

Gary L Johnson

2 joint publications

Alexander V Lobanov